Qilian International Holding Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Qilian International Holding Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Qilian International Holding Group Ltd (NASDAQ:QLI) ("Qilian" or the "Company"), a China-based pharmaceutical and chemical products manufacturer, received notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq"), dated July 13, 2023, that the Company is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on The Nasdaq Global Market (the "Nasdaq Global Market"). The Notification Letter is only a notification of deficiency and not a notice of delisting.
總部位於中國的醫藥和化工產品製造商啓聯國際控股集團有限公司（納斯達克股票代碼：QLI）（“啓聯” 或 “公司”）於2023年7月13日收到納斯達克股票市場有限責任公司（“納斯達克全球市場”）的通知（“通知信”），稱該公司未遵守納斯達克上市規則中規定的繼續在納斯達克全球市場（“納斯達克全球市場”）上市的最低出價要求”）。通知信只是缺陷通知，不是除名通知。
Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's ordinary shares for the 30 consecutive business days from May 30, 2023 to July 12, 2023, the Company no longer meets the minimum bid price requirement.
納斯達克上市規則5450 (a) (1) 要求上市證券將最低出價維持在每股1.00美元，納斯達克上市規則5810 (c) (3) (A) 規定，如果缺口持續30個工作日，則不符合最低出價要求。根據2023年5月30日至2023年7月12日連續30個工作日公司普通股的收盤價，公司不再符合最低出價要求。
The Notification Letter does not impact the Company's listing on the Nasdaq Global Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until January 9, 2024 (the "Compliance Period"), to regain compliance with Nasdaq Listing Rule 5450(a)(1). To regain compliance, the Company's ordinary shares must have a closing bid price of at least US$1.00 for a minimum for 10 consecutive business days, and shall not have a closing bid price of $0.10 or less for ten consecutive trading days during the Compliance Period. In the event the Company does not regain compliance by January 9, 2024, the Company may be eligible for additional time to regain compliance or may face delisting, as the case may be.
通知信不影響公司目前在納斯達克全球市場的上市。根據納斯達克上市規則5810 (c) (3) (A)，公司有180個日曆日，或在2024年1月9日（“合規期”）之前，重新遵守納斯達克上市規則5450 (a) (1)。爲了恢復合規，公司普通股的收盤價必須在連續10個工作日內至少爲1.00美元，並且在合規期內連續十個交易日的收盤價不得低於0.10美元。如果公司在2024年1月9日之前仍未恢復合規，則公司可能有資格獲得更多時間來恢復合規，或者可能面臨退市（視情況而定）。
The Company's business operations are not affected by the receipt of the Notification Letter. The Company intends to monitor the closing bid price of its ordinary shares and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse share split of its outstanding ordinary shares, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.
收到通知信後，公司的業務運營不受影響。公司打算監控其普通股的收盤價，並可能在適當時考慮實施可用期權，包括但不限於對其已發行普通股進行反向分股，以重新遵守納斯達克上市規則下的最低出價要求。
譯文內容由第三人軟體翻譯。